New Test Helps Reveal Data on Immune Response to Sars-Cov-2 Following Organ Transplantation

A new test that provides information on the immune response to the novel coronavirus in patients who need to take immunosuppressive drugs has been developed.

Scientists have developed a new test that provides information on the immune response to the novel coronavirus in patients who need to take immunosuppressive drugs. The test was developed by University Hospital at Ruhr-Universität Bochum (RUB) researchers.

This is necessary, for instance, following an organ transplantation. "We were able to show that these patients can achieve a good immune response to Sars-Cov-2 despite immunosuppression," says Professor Nina Babel, Head of the Centre for Translational Medicine at Marien Hospital Herne. Immunosuppressive therapy can be adapted individually during a Covid-19 infection using the test. The researchers report in the American Journal of Transplantation.

Quiz on Organ Donation and Transplantation
See how much you know about organ donation and transplantation by taking this quiz.

‘Chronically ill patients with impaired immune defences have an increased risk of suffering from a severe COVID-19 infection.’

Risk for organ transplant patients twice as high

Transplant patients are affected in several ways: in addition to the chronic illness that led to organ failure and subsequent transplantation, transplant patients need to take medications that suppress the defences of their own immune system.

"These immunosuppressants are necessary to prevent the body from rejecting transplanted organs. However, they can lead to an abundance of viral infections," explains Nina Babel, who, together with Professor Timm Westhoff, Director of Medical Clinic I at Marien Hospital Herne, led the team, including researchers from the Department of Molecular and Medical Virology at RUB and the Surgical Clinic at Knappschaftskrankenhauses Langendreer. "Until now, it has not been known whether our transplant patients are capable of forming a sufficient immune response to the new coronavirus," emphasises Timm Westhoff.

Coronavirus
Coronaviruses infect animals, humans, and birds. Human coronaviruses, such as SARS, MERS, and 2019-nCoV cause respiratory distress and even death. The S protein is the infectious agent of the virus.

Immune response despite suppressing drugs

With the help of the test established in the Marien Hospital's immunodiagnostics laboratory, the team demonstrated that transplant patients are very capable of achieving a good immune response despite immunosuppression. In addition to high antibody titres, large quantities of T lymphocytes, which are responsible for killing infected cells, were found in the current case study.

Trials Likely to Resume After Interruption Due to COVID-19
The majority of clinical trial disruptions are mainly due to the suspension of enrollment of subjects, followed by slow enrollment, and delayed initiation.

The test is of great clinical relevance for transplant patients: the information provided by this goes far beyond a pure antibody test. "The data obtained help us to deal with immunosuppression during the current pandemic," emphasises Timm Westhoff. "The test allows us to individually adjust immunosuppression when a patient is suffering from Covid-19."

Source-Eurekalert

Clinic Visits Doesn't Raise the Risk of Getting COVID-19
A US study of pregnant patients during the pandemic has found that in-person health care visits were not an important risk factor for contracting the COVID-19 infection.